Editas Medicine, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Editas Medicine, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Editas Medicine, Inc. Return On Assets for the quarter ending June 30, 2024 was -42.3 %, a 5.43% decline year-over-year.
  • Editas Medicine, Inc. annual Return On Assets for 2023 was -30.5 %, a 22.2% increase from 2022.
  • Editas Medicine, Inc. annual Return On Assets for 2022 was -39.2 %, a 49.2% decline from 2021.
  • Editas Medicine, Inc. annual Return On Assets for 2021 was -26.3 %, a 29.8% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -30.5 +8.71 +22.2% Jan 1, 2023 Dec 31, 2023
2022 -39.2 -12.9 -49.2% Jan 1, 2022 Dec 31, 2022
2021 -26.3 -6.03 -29.8% Jan 1, 2021 Dec 31, 2021
2020 -20.2 +12.9 +38.9% Jan 1, 2020 Dec 31, 2020
2019 -33.1 -5.72 -20.9% Jan 1, 2019 Dec 31, 2019
2018 -27.4 +5.21 +16% Jan 1, 2018 Dec 31, 2018
2017 -32.6 +7.48 +18.7% Jan 1, 2017 Dec 31, 2017
2016 -40.1 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.